Pneumococcal Vaccine Market Report by Vaccine Type (Pneumococcal Conjugate Vaccine, Pneumococcal Polysaccharide Vaccine), Product Type (Prevnar 13, Synflorix, Pneumovax 23), Distribution Channel (Distribution Partner Companies, Non-Governmental Organizations (NGO), Government Authorities), End User (Pediatrics, Adults), and Region 2025-2033

Pneumococcal Vaccine Market Report by Vaccine Type (Pneumococcal Conjugate Vaccine, Pneumococcal Polysaccharide Vaccine), Product Type (Prevnar 13, Synflorix, Pneumovax 23), Distribution Channel (Distribution Partner Companies, Non-Governmental Organizations (NGO), Government Authorities), End User (Pediatrics, Adults), and Region 2025-2033

Report Format: PDF+Excel | Report ID: SR112025A3133

1   Preface
2   Scope and Methodology

    2.1   Objectives of the Study
    2.2   Stakeholders
    2.3   Data Sources
        2.3.1   Primary Sources
        2.3.2   Secondary Sources
    2.4   Market Estimation
        2.4.1   Bottom-Up Approach
        2.4.2   Top-Down Approach
    2.5   Forecasting Methodology
3   Executive Summary
4   Introduction

    4.1   Overview
    4.2   Key Industry Trends
5   Global Pneumococcal Vaccine Market
    5.1   Market Overview
    5.2   Market Performance
    5.3   Impact of COVID-19
    5.4   Market Forecast
6    Market Breakup by Vaccine Type
     6.1   Pneumococcal Conjugate Vaccine
        6.1.1  Market Trends
        6.1.2  Market Forecast
     6.2   Pneumococcal Polysaccharide Vaccine
        6.2.1  Market Trends
        6.2.2  Market Forecast
7    Market Breakup by Product Type
     7.1   Prevnar 13
        7.1.1  Market Trends
        7.1.2  Market Forecast
     7.2   Synflorix
        7.2.1  Market Trends
        7.2.2  Market Forecast
     7.3   Pneumovax 23
        7.3.1  Market Trends
        7.3.2  Market Forecast
8    Market Breakup by Distribution Channel
     8.1   Distribution Partner Companies
        8.1.1  Market Trends
        8.1.2  Market Forecast
     8.2   Non-Governmental Organizations (NGO)
        8.2.1  Market Trends
        8.2.2  Market Forecast
     8.3   Government Authorities
        8.3.1  Market Trends
        8.3.2  Market Forecast
9    Market Breakup by End User
     9.1   Pediatrics
        9.1.1  Market Trends
        9.1.2  Market Forecast
     9.2   Adults
        9.2.1  Market Trends
        9.2.2  Market Forecast
10   Market Breakup by Region
     10.1   North America
          10.1.1   United States
               10.1.1.1  Market Trends
               10.1.1.2  Market Forecast
          10.1.2   Canada
               10.1.2.1  Market Trends
               10.1.2.2  Market Forecast
     10.2   Asia-Pacific
          10.2.1   China
               10.2.1.1  Market Trends
               10.2.1.2  Market Forecast
          10.2.2   Japan
               10.2.2.1  Market Trends
               10.2.2.2  Market Forecast
          10.2.3   India
               10.2.3.1  Market Trends
               10.2.3.2  Market Forecast
          10.2.4   South Korea
               10.2.4.1  Market Trends
               10.2.4.2  Market Forecast
          10.2.5   Australia
               10.2.5.1  Market Trends
               10.2.5.2  Market Forecast
          10.2.6   Indonesia
               10.2.6.1  Market Trends
               10.2.6.2  Market Forecast
          10.2.7   Others
               10.2.7.1  Market Trends
               10.2.7.2  Market Forecast
     10.3   Europe
          10.3.1   Germany
               10.3.1.1  Market Trends
               10.3.1.2  Market Forecast
          10.3.2   France
               10.3.2.1  Market Trends
               10.3.2.2  Market Forecast
          10.3.3   United Kingdom
               10.3.3.1  Market Trends
               10.3.3.2  Market Forecast
          10.3.4   Italy
               10.3.4.1  Market Trends
               10.3.4.2  Market Forecast
          10.3.5   Spain
               10.3.5.1  Market Trends
               10.3.5.2  Market Forecast
          10.3.6   Russia
               10.3.6.1  Market Trends
               10.3.6.2  Market Forecast
          10.3.7   Others
               10.3.7.1  Market Trends
               10.3.7.2  Market Forecast
     10.4   Latin America
          10.4.1   Brazil
               10.4.1.1  Market Trends
               10.4.1.2  Market Forecast
          10.4.2   Mexico
               10.4.2.1  Market Trends
               10.4.2.2  Market Forecast
          10.4.3   Others
               10.4.3.1  Market Trends
               10.4.3.2  Market Forecast
     10.5   Middle East and Africa
          10.5.1  Market Trends
          10.5.2  Market Breakup by Country
          10.5.3  Market Forecast
11  SWOT Analysis
    11.1   Overview
    11.2   Strengths
    11.3   Weaknesses
    11.4   Opportunities
    11.5   Threats
12  Value Chain Analysis
13  Porters Five Forces Analysis

    13.1   Overview
    13.2   Bargaining Power of Buyers
    13.3   Bargaining Power of Suppliers
    13.4   Degree of Competition
    13.5   Threat of New Entrants
    13.6   Threat of Substitutes
14  Price Analysis
15  Competitive Landscape

    15.1   Market Structure
    15.2   Key Players
    15.3   Profiles of Key Players
         15.3.1   Astellas Pharma Inc.
              15.3.1.1   Company Overview
              15.3.1.2   Product Portfolio
              15.3.1.3   Financials
              15.3.1.4   SWOT Analysis
         15.3.2   GlaxoSmithKline Plc.
              15.3.2.1   Company Overview
              15.3.2.2   Product Portfolio
              15.3.2.3   Financials
              15.3.2.4   SWOT Analysis
         15.3.3   Merck & Co. Inc.
              15.3.3.1   Company Overview
              15.3.3.2   Product Portfolio
              15.3.3.3   Financials
              15.3.3.4   SWOT Analysis
         15.3.4   Panacea Biotec Ltd.
              15.3.4.1   Company Overview
              15.3.4.2   Product Portfolio
              15.3.4.3   Financials
              15.3.4.4   SWOT Analysis
         15.3.5   Pfizer Inc.
              15.3.5.1   Company Overview
              15.3.5.2   Product Portfolio
              15.3.5.3   Financials
              15.3.5.4   SWOT Analysis
         15.3.6   Sanofi S.A.
              15.3.6.1   Company Overview
              15.3.6.2   Product Portfolio
              15.3.6.3   Financials
              15.3.6.4   SWOT Analysis
         15.3.7   Serum Institute of India Pvt Ltd.
              15.3.7.1   Company Overview
              15.3.7.2   Product Portfolio
         15.3.8   Walvax Biotechnology Co. Ltd.
              15.3.8.1   Company Overview
              15.3.8.2   Product Portfolio
              15.3.8.3   Financials

List of Figures

Figure 1: Global: Pneumococcal Vaccine Market: Major Drivers and Challenges
Figure 2: Global: Pneumococcal Vaccine Market: Sales Value (in Billion USD), 2019-2024
Figure 3: Global: Pneumococcal Vaccine Market Forecast: Sales Value (in Billion USD), 2025-2033
Figure 4: Global: Pneumococcal Vaccine Market: Breakup by Vaccine Type (in %), 2024
Figure 5: Global: Pneumococcal Vaccine Market: Breakup by Product Type (in %), 2024
Figure 6: Global: Pneumococcal Vaccine Market: Breakup by Distribution Channel (in %), 2024
Figure 7: Global: Pneumococcal Vaccine Market: Breakup by End User (in %), 2024
Figure 8: Global: Pneumococcal Vaccine Market: Breakup by Region (in %), 2024
Figure 9: Global: Pneumococcal Vaccine (Pneumococcal Conjugate Vaccine) Market: Sales Value (in Million USD), 2019 & 2024
Figure 10: Global: Pneumococcal Vaccine (Pneumococcal Conjugate Vaccine) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 11: Global: Pneumococcal Vaccine (Pneumococcal Polysaccharide Vaccine) Market: Sales Value (in Million USD), 2019 & 2024
Figure 12: Global: Pneumococcal Vaccine (Pneumococcal Polysaccharide Vaccine) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 13: Global: Pneumococcal Vaccine (Prevnar 13) Market: Sales Value (in Million USD), 2019 & 2024
Figure 14: Global: Pneumococcal Vaccine (Prevnar 13) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 15: Global: Pneumococcal Vaccine (Synflorix) Market: Sales Value (in Million USD), 2019 & 2024
Figure 16: Global: Pneumococcal Vaccine (Synflorix) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 17: Global: Pneumococcal Vaccine (Pneumovax 23) Market: Sales Value (in Million USD), 2019 & 2024
Figure 18: Global: Pneumococcal Vaccine (Pneumovax 23) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 19: Global: Pneumococcal Vaccine (Distribution Partner Companies) Market: Sales Value (in Million USD), 2019 & 2024
Figure 20: Global: Pneumococcal Vaccine (Distribution Partner Companies) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 21: Global: Pneumococcal Vaccine (Non-Governmental Organizations-NGO) Market: Sales Value (in Million USD), 2019 & 2024
Figure 22: Global: Pneumococcal Vaccine (Non-Governmental Organizations-NGO) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 23: Global: Pneumococcal Vaccine (Government Authorities) Market: Sales Value (in Million USD), 2019 & 2024
Figure 24: Global: Pneumococcal Vaccine (Government Authorities) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 25: Global: Pneumococcal Vaccine (Pediatrics) Market: Sales Value (in Million USD), 2019 & 2024
Figure 26: Global: Pneumococcal Vaccine (Pediatrics) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 27: Global: Pneumococcal Vaccine (Adults) Market: Sales Value (in Million USD), 2019 & 2024
Figure 28: Global: Pneumococcal Vaccine (Adults) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 29: North America: Pneumococcal Vaccine Market: Sales Value (in Million USD), 2019 & 2024
Figure 30: North America: Pneumococcal Vaccine Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 31: United States: Pneumococcal Vaccine Market: Sales Value (in Million USD), 2019 & 2024
Figure 32: United States: Pneumococcal Vaccine Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 33: Canada: Pneumococcal Vaccine Market: Sales Value (in Million USD), 2019 & 2024
Figure 34: Canada: Pneumococcal Vaccine Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 35: Asia-Pacific: Pneumococcal Vaccine Market: Sales Value (in Million USD), 2019 & 2024
Figure 36: Asia-Pacific: Pneumococcal Vaccine Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 37: China: Pneumococcal Vaccine Market: Sales Value (in Million USD), 2019 & 2024
Figure 38: China: Pneumococcal Vaccine Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 39: Japan: Pneumococcal Vaccine Market: Sales Value (in Million USD), 2019 & 2024
Figure 40: Japan: Pneumococcal Vaccine Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 41: India: Pneumococcal Vaccine Market: Sales Value (in Million USD), 2019 & 2024
Figure 42: India: Pneumococcal Vaccine Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 43: South Korea: Pneumococcal Vaccine Market: Sales Value (in Million USD), 2019 & 2024
Figure 44: South Korea: Pneumococcal Vaccine Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 45: Australia: Pneumococcal Vaccine Market: Sales Value (in Million USD), 2019 & 2024
Figure 46: Australia: Pneumococcal Vaccine Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 47: Indonesia: Pneumococcal Vaccine Market: Sales Value (in Million USD), 2019 & 2024
Figure 48: Indonesia: Pneumococcal Vaccine Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 49: Others: Pneumococcal Vaccine Market: Sales Value (in Million USD), 2019 & 2024
Figure 50: Others: Pneumococcal Vaccine Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 51: Europe: Pneumococcal Vaccine Market: Sales Value (in Million USD), 2019 & 2024
Figure 52: Europe: Pneumococcal Vaccine Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 53: Germany: Pneumococcal Vaccine Market: Sales Value (in Million USD), 2019 & 2024
Figure 54: Germany: Pneumococcal Vaccine Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 55: France: Pneumococcal Vaccine Market: Sales Value (in Million USD), 2019 & 2024
Figure 56: France: Pneumococcal Vaccine Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 57: United Kingdom: Pneumococcal Vaccine Market: Sales Value (in Million USD), 2019 & 2024
Figure 58: United Kingdom: Pneumococcal Vaccine Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 59: Italy: Pneumococcal Vaccine Market: Sales Value (in Million USD), 2019 & 2024
Figure 60: Italy: Pneumococcal Vaccine Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 61: Spain: Pneumococcal Vaccine Market: Sales Value (in Million USD), 2019 & 2024
Figure 62: Spain: Pneumococcal Vaccine Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 63: Russia: Pneumococcal Vaccine Market: Sales Value (in Million USD), 2019 & 2024
Figure 64: Russia: Pneumococcal Vaccine Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 65: Others: Pneumococcal Vaccine Market: Sales Value (in Million USD), 2019 & 2024
Figure 66: Others: Pneumococcal Vaccine Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 67: Latin America: Pneumococcal Vaccine Market: Sales Value (in Million USD), 2019 & 2024
Figure 68: Latin America: Pneumococcal Vaccine Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 69: Brazil: Pneumococcal Vaccine Market: Sales Value (in Million USD), 2019 & 2024
Figure 70: Brazil: Pneumococcal Vaccine Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 71: Mexico: Pneumococcal Vaccine Market: Sales Value (in Million USD), 2019 & 2024
Figure 72: Mexico: Pneumococcal Vaccine Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 73: Others: Pneumococcal Vaccine Market: Sales Value (in Million USD), 2019 & 2024
Figure 74: Others: Pneumococcal Vaccine Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 75: Middle East and Africa: Pneumococcal Vaccine Market: Sales Value (in Million USD), 2019 & 2024
Figure 76: Middle East and Africa: Pneumococcal Vaccine Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 77: Middle East and Africa: Pneumococcal Vaccine Market: Breakup by Country (in %), 2024
Figure 78: Global: Pneumococcal Vaccine Industry: SWOT Analysis
Figure 79: Global: Pneumococcal Vaccine Industry: Value Chain Analysis
Figure 80: Global: Pneumococcal Vaccine Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Pneumococcal Vaccine Market: Key Industry Highlights, 2024 and 2033
Table 2: Global: Pneumococcal Vaccine Market Forecast: Breakup by Vaccine Type (in Million USD), 2025-2033
Table 3: Global: Pneumococcal Vaccine Market Forecast: Breakup by Product Type (in Million USD), 2025-2033
Table 4: Global: Pneumococcal Vaccine Market Forecast: Breakup by Distribution Channel (in Million USD), 2025-2033
Table 5: Global: Pneumococcal Vaccine Market Forecast: Breakup by End User (in Million USD), 2025-2033
Table 6: Global: Pneumococcal Vaccine Market Forecast: Breakup by Region (in Million USD), 2025-2033
Table 7: Global: Pneumococcal Vaccine Market: Competitive Structure
Table 8: Global: Pneumococcal Vaccine Market: Key Players

Pneumococcal Vaccine Market Report by Vaccine Type (Pneumococcal Conjugate Vaccine, Pneumococcal Polysaccharide Vaccine), Product Type (Prevnar 13, Synflorix, Pneumovax 23), Distribution Channel (Distribution Partner Companies, Non-Governmental Organizations (NGO), Government Authorities), End User (Pediatrics, Adults), and Region 2025-2033
Purchase Options New Year Sale
Benefits of Customization
  • Personalize this research
  • Triangulate with your data
  • Get data as per your format and definition
  • Gain a deeper dive into a specific application, geography, customer, or competitor
  • Any level of personalization

Get in Touch With Us

UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-714-6104

Email: sales@imarcgroup.com

Client Testimonials